A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

Autor: Santoro, Armando 1, 2, ∗, Assenat, Eric 3, Yau, Thomas 4, Delord, Jean-Pierre 5, Maur, Michela 6, Knox, Jennifer 7, Cattan, Stephane 8, Lee, Kyung-Hun 9, Del Conte, Gianluca 10, Springfeld, Christoph 11, Leo, Elisa 12, Xyrafas, Alexandros 12, Fairchild, Lauren 13, Mardjuadi, Feby 14, Chan, Stephen L. 15
Zdroj: In JHEP Reports April 2024 6(4)
Databáze: ScienceDirect